Abbott Laboratories closed $8.24 below its 52-week high ($121.64), which the company achieved on March 8th.

Shares of Abbott Laboratories ABT shed 0.69% to $113.04 Monday, on what proved to be an all-around mixed trading session for ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliable and data-driven approach ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...

In a report released on January 6, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $113.83 which represents a slight increase of $0.39 or 0.34% from the prior close of $113.44. The stock opened at $113.94 and ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The ...

Abbott Laboratories (NYSE:ABT – Free Report) had its price objective boosted by Evercore ISI to $136.00 in a report released on Thursday morning,Stock Target Advisor reports. They currently have a buy ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been one ...